Sign in

CIK 0001623526

  • Non-accelerated filer
  • Smaller reporting company

Stoke Therapeutics, Inc.

Sign in to watch
Ticker
STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
471144582
Phone
+1 781-430-8200
Business address
45 WIGGINS AVENUE, BEDFORD, MA, 01730
Former names
ASOthera Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$403,975
in 4 filings, $404K under 10b5-1 plans

Net −$403,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-06-01 Liau Gene EVP Research & Preclinical Dev Exercise or conversion · Employee Stock Option (right to buy) −20,000 71,889
2020-06-01 Nash Huw M. COO & CBO Exercise or conversion +2,107 $2.19 $5K 2,107
2020-06-01 Nash Huw M. COO & CBO Sale −1,607 $27.08 $44K 500
2020-06-01 Nash Huw M. COO & CBO Sale −500 $27.48 $14K 0
2020-06-01 Nash Huw M. COO & CBO Exercise or conversion · Employee Stock Option (Right to Buy) −2,107 228,711
2020-05-22 Liau Gene EVP Research & Preclinical Dev Exercise or conversion +7,500 $0.60 $5K 21,000
2020-05-22 Liau Gene EVP Research & Preclinical Dev Sale −7,500 $30.00 $225K 13,500
2020-05-22 Liau Gene EVP Research & Preclinical Dev Exercise or conversion · Employee Stock Option (right to buy) −7,500 134,066
2020-03-31 Liau Gene EVP Research & Preclinical Dev Exercise or conversion · Employee Stock Option (right to buy) −7,500 141,566
2020-03-31 Liau Gene EVP Research & Preclinical Dev Exercise or conversion +7,500 $0.60 $5K 13,500
2020-03-31 Liau Gene EVP Research & Preclinical Dev Exercise or conversion · Employee Stock Option (right to buy) +7,500 141,566
2020-03-25 Walker Robin A. Chief Legal Officer, CCO & Sec Grant or award · Employee Stock Option (Right to Buy) +60,000 60,000
2020-03-25 Tulipano Stephen J CFO Grant or award · Employee Stock Option (Right to Buy) +60,000 60,000
2020-03-25 Ticho Barry Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +60,000 60,000
2020-03-25 Liau Gene EVP Research & Preclinical Dev Grant or award · Employee Stock Option (Right to Buy) +42,000 42,000
2020-03-25 Kaye Edward M. MD CEO Grant or award · Employee Stock Option (Right to Buy) +197,000 197,000
2020-03-25 Nash Huw M. COO & CBO Grant or award · Employee Stock Option (Right to Buy) +60,000 60,000
2020-03-02 Nash Huw M. COO & CBO Exercise or conversion +6,324 $0.40 $3K 6,324
2020-03-02 Nash Huw M. COO & CBO Exercise or conversion +42,779 $2.19 $94K 49,103
2020-03-02 Nash Huw M. COO & CBO Sale −33,148 $25.66 $851K 15,995

Page 32 of 35 · 681 trades